COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

1 Killed in Train Crash at E 52nd Street


Victim Hit by Metro Blue Line Rail Car in Fatal Los Angeles Accident

Los Angeles, CA (September 12, 2020) – A pedestrian was killed in a train crash in Los Angeles. The fatal accident occurred on the evening of September 12 on E 52nd Street.

A man was hit by a Metro Blue Line rail car in the 1659 block of E 52nd Street. He died at the accident scene. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Los Angeles

#90011


March 20, 2020

1 Seriously Injured in Crash on Interstate 5 Freeway at Olive Avenue

3 Vehicles Involved in Burbank Accident ...


July 8, 2020

Teen Killed in Crash on Monte Vista Avenue

5 Injured in Fatal Montclair Accident...


March 13, 2020

Woman Killed in Crash on Knabe Road

Motorcycle, Car Collide in Fatal Los Angeles Accident ...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.